The dryness was the least of it, honestly. It was the burning when sitting in certain chairs, the constant feeling that a UTI was coming, and the way intimacy changed texture entirely — those were the things that quietly dismantled confidence. Nobody warned that estrogen was holding all of that together, and that realisation, when it finally came, was both a relief and a kind of grief.
Learn more about Rose →As estrogen declines, the vaginal epithelium thins and loses its glycogen-rich surface cells, which shifts the local pH from acidic to alkaline. This pH change, combined with reduced moisture and nerve sensitivity changes, produces a persistent burning sensation that is entirely independent of any infection. Many women cycle through multiple negative swab tests before GSM is considered as the actual cause.
Thinning of the vulvar and vaginal tissues — a process called vulvovaginal atrophy — reduces the natural cushioning that surrounds the vulva and vestibule, making pressure from sitting on hard surfaces or tight clothing genuinely painful. This symptom is frequently dismissed or attributed to an unrelated dermatological condition, delaying appropriate treatment by months or years. The discomfort tends to worsen the longer GSM goes unaddressed, because tissue atrophy is progressive without estrogenic support.
The urethra and bladder trigone are rich in estrogen receptors, and when estrogen falls, the protective Lactobacillus-dominant microbiome of the vaginal ecosystem collapses, allowing pathogenic bacteria to colonise more easily and ascend to the bladder. Studies show postmenopausal women have significantly higher rates of recurrent UTIs compared to premenopausal women, and this is directly tied to the loss of estrogenic support in the genitourinary tract. Vaginal estrogen has been shown in multiple trials to reduce recurrent UTI frequency, confirming the hormonal mechanism.
Estrogen helps maintain the elasticity and sensitivity of the bladder wall and urethra; as levels drop, the bladder can become overactive, firing urgency signals even when it is only partially full. Women describe a sudden, almost uncontrollable need to urinate that bears little relationship to how much fluid they have consumed. This is classified as urgency urinary incontinence when leakage follows, but many women experience the urgency alone and don't connect it to menopause at all.
The urethral sphincter and surrounding connective tissue depend on estrogen to maintain their tone and structural integrity; without it, the closure pressure of the urethra decreases, making it easier for sudden intra-abdominal pressure spikes — from coughing, sneezing, or laughing — to overwhelm the sphincter. This is stress urinary incontinence, and while pelvic floor muscle training remains the first-line intervention, estrogen deficiency is a recognised contributing factor. It is worth noting that stress incontinence and urgency incontinence frequently coexist in the same person, a pattern called mixed urinary incontinence.
Dyspareunia, or pain with penetration, is one of the most clinically well-documented symptoms of GSM and is caused by a combination of reduced lubrication, thinned epithelium, and decreased elasticity of the vaginal canal, which can actually shorten and narrow over time without estrogenic stimulation. The pain is often described as tearing, rawness, or a burning sensation during or after intercourse, and post-coital bleeding from microabrasions is also common. Crucially, dyspareunia tends to worsen with sexual inactivity, because regular gentle stimulation helps maintain tissue health — a fact that feels deeply unfair but is physiologically real.
Orgasm involves a complex interplay of blood flow, nerve conduction, and muscle contraction, all of which are influenced by estrogen and testosterone; as both decline in the menopausal transition, clitoral sensitivity can reduce, time to orgasm can lengthen, and the intensity of orgasm itself may feel blunted or altered. Reduced blood flow to the clitoris and vaginal wall is part of the mechanism — estrogen normally supports the vascular engorgement that underlies arousal. This is a real physiological change, not a psychological one, though the two can interact and compound each other.
Some women with GSM describe a persistent low-grade sense of pressure, heaviness, or 'something sitting there' in the vaginal or perineal region that is not pain exactly but is chronically uncomfortable. This can be related to reduced tissue tone and altered pelvic floor dynamics as estrogen withdrawal affects the supportive connective tissues of the pelvic floor, and it can also overlap with early pelvic organ prolapse, which becomes more common after menopause. Any new sensation of vaginal heaviness warrants a pelvic assessment to rule out prolapse as a contributing factor.
The urethra shares its embryological origins with the vaginal tissue and is equally estrogen-dependent; as the urethral mucosa thins, passing urine can produce a stinging or burning sensation that mimics a UTI but persists even when urine cultures come back clear. This is sometimes called urethral syndrome and is a recognised manifestation of GSM that is frequently overtreated with antibiotics that do nothing to address the root cause. Women who notice burning on urination alongside a string of negative urine cultures should specifically ask their clinician about GSM as the explanation.
Vulvar itching in GSM stems from the same mechanism as burning: thinned, fragile epithelium with disrupted barrier function and altered pH creates an environment that is easily irritated and prone to dryness-driven itch signals. The itching often worsens at night, partly because there are fewer distractions and partly because warmth under bedcovers can intensify the sensation. It is important to distinguish GSM-related itch from other dermatological conditions such as lichen sclerosus, which can coexist with GSM and requires its own specific treatment.
Healthy premenopausal vaginal tissue is characterised by rugae — the accordion-like folds that allow the vaginal canal to expand — and these folds gradually flatten and disappear as estrogen-dependent collagen support is withdrawn. Women sometimes describe noticing this change as a loss of sensation during sex, or a partner noticing that things feel 'different,' which can be emotionally confusing without context. This structural change is measurable on clinical examination using validated tools like the Vaginal Health Index, and it confirms that what feels subjectively different is anatomically real.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.